YUVIWEL

navepegritide · Ascendis Pharma Endocrinology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YUVIWEL, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: FDA Approved: YUVIWEL — Original Application (Ascendis Pharma Endocrinology, Inc.)